142 related articles for article (PubMed ID: 30998516)
1. Dermatological Implications of Galectin-3 in Circulation: An Evaluation From the Perspective of Patients With Differential Manifestations of Post-Kala-Azar Dermal Leishmaniasis.
Datta S; Ghosh M; Dewan K; Banerjee N; Saha B; Mukhopadhyay S
Am J Dermatopathol; 2019 Dec; 41(12):897-907. PubMed ID: 30998516
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
[TBL] [Abstract][Full Text] [Related]
3. In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
Sengupta R; Mukherjee S; Moulik S; Mitra S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():166-176. PubMed ID: 31542359
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
[TBL] [Abstract][Full Text] [Related]
6. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anti-gal enzyme-linked immunosorbent assay for the diagnosis of Indian post-kala-azar dermal leishmaniasis.
Datta S; Ghosh M; Sarkar S; Saha B; Mukhopadhyay S
Indian J Dermatol Venereol Leprol; 2019; 85(6):578-589. PubMed ID: 31397399
[TBL] [Abstract][Full Text] [Related]
8. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
Katara GK; Ansari NA; Singh A; Ramesh V; Salotra P
PLoS Negl Trop Dis; 2012; 6(6):e1703. PubMed ID: 22724038
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis.
Singh AK; Das VNR; Amit A; Dikhit MR; Mahantesh V; Singh SK; Naryan S; Pandey K; Das P; Verma N; Bimal S
J Cell Biochem; 2018 Sep; 119(9):7406-7418. PubMed ID: 29775225
[TBL] [Abstract][Full Text] [Related]
10. Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India.
Jaiswal P; Datta S; Sardar B; Chaudhuri SJ; Maji D; Ghosh M; Saha B; Mukhopadhyay S
PLoS One; 2018; 13(2):e0192302. PubMed ID: 29420575
[TBL] [Abstract][Full Text] [Related]
11. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of blood based quantitative PCR as a molecular diagnostic tool for post kala-azar dermal leishmaniasis (PKDL).
Kumar A; Singh VK; Madhukar P; Tiwari R; Roy R; Rajneesh ; Mehrotra S; Sundar S; Kumar R
Mol Biol Rep; 2024 Jun; 51(1):716. PubMed ID: 38824237
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study.
Verma N; Bimal S; Das VN; Pandey K; Singh D; Lal CS; Singh AK; Sinha PK; Das P
Biomed Res Int; 2015; 2015():745062. PubMed ID: 26090441
[TBL] [Abstract][Full Text] [Related]
14. A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone.
Mukhopadhyay D; Mukherjee S; Ghosh S; Roy S; Saha B; Das NK; Chatterjee M
Int J Dermatol; 2016 May; 55(5):e250-5. PubMed ID: 26536363
[TBL] [Abstract][Full Text] [Related]
15. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
Gasim S; Elhassan AM; Kharazmi A; Khalil EA; Ismail A; Theander TG
Clin Exp Immunol; 2000 Mar; 119(3):523-9. PubMed ID: 10691926
[TBL] [Abstract][Full Text] [Related]
16. Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S; Das NK; Barbhuiya JN; Chatterjee M
Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917
[TBL] [Abstract][Full Text] [Related]
17. Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
Vijayamahantesh ; Amit A; Dikhit MR; Pandey RK; Singh K; Mishra R; Das VN; Das P; Bimal S
PLoS One; 2016; 11(5):e0154117. PubMed ID: 27186641
[TBL] [Abstract][Full Text] [Related]
18. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
[TBL] [Abstract][Full Text] [Related]
19. Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.
Mukherjee S; Mukhopadhyay D; Ghosh S; Barbhuiya JN; Das NK; Chatterjee M
J Clin Immunol; 2016 Jan; 36(1):85-94. PubMed ID: 26644312
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.
Islam S; Kenah E; Bhuiyan MA; Rahman KM; Goodhew B; Ghalib CM; Zahid MM; Ozaki M; Rahman MW; Haque R; Luby SP; Maguire JH; Martin D; Bern C
Am J Trop Med Hyg; 2013 Aug; 89(2):345-53. PubMed ID: 23817330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
